Feb 5, 2019 | Anti-METH antibody, IXT-m200, Anti-METH Vaccine, METH in the news
Stimulant use disorders, specifically cocaine and methamphetamine use, present ongoing public health problems in the United States, with major medical, psychiatric, cognitive, socioeconomic, and legal consequences. Source: Pharmacotherapy for Stimulant Use Disorders:...
Jan 29, 2015 | Anti-METH antibody, IXT-m200, Anti-METH Vaccine, General News, Grants, Uncategorized
LITTLE ROCK – A University of Arkansas for Medical Sciences (UAMS) BioVentures startup company, InterveXion Therapeutics LLC, has received two federal grants totaling $14.5 million for development of drug therapies that can help methamphetamine drug abusers break...
Recent Comments